Sam Chun Dang Pharm. Co. Ltd (000250) — Cash Flow Quality Index
Sam Chun Dang Pharm. Co. Ltd (000250) has a Cash Flow Quality Index of 0.96x as of March 2025. Operating cash flow of ₩1.23 Billion is below net income of ₩1.28 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Sam Chun Dang Pharm. Co. Ltd (000250) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sam Chun Dang Pharm. Co. Ltd Cash Flow Quality Index (2012–2022)
Historical Cash Flow Quality Index for Sam Chun Dang Pharm. Co. Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 000250 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Sam Chun Dang Pharm. Co. Ltd (2012–2022)
Year-by-year earnings quality comparison for Sam Chun Dang Pharm. Co. Ltd. For live market cap and the full company financial profile, see Sam Chun Dang Pharm. Co. Ltd stock valuation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 2.27x | ₩13.28 Billion | ₩5.84 Billion | ▲ +55.3% |
| 2019 | 1.46x | ₩30.60 Billion | ₩20.89 Billion | ▼ -20.7% |
| 2018 | 1.85x | ₩25.03 Billion | ₩13.55 Billion | ▼ -11.4% |
| 2017 | 2.08x | ₩26.09 Billion | ₩12.51 Billion | ▲ +83.2% |
| 2016 | 1.14x | ₩17.76 Billion | ₩15.61 Billion | ▲ +17.3% |
| 2015 | 0.97x | ₩17.34 Billion | ₩17.87 Billion | ▼ -41.2% |
| 2014 | 1.65x | ₩19.55 Billion | ₩11.85 Billion | ▼ -9.7% |
| 2013 | 1.83x | ₩15.94 Billion | ₩8.72 Billion | ▲ +52.9% |
| 2012 | 1.20x | ₩1.60 Billion | ₩1.34 Billion | — |